
Ultrasound diagnosis could lead to faster treatment of endometriosis
Endometriosis can take years to be diagnosed, as it has previously required waiting for a surgical procedure to make the diagnosis.
The condition causes severe pain, infertility and heavy periods – and occurs when cells similar to the lining of the uterus grow in other parts of the body. As well as women, endometriosis also affects other people with a uterus and a small number of men.
The living evidence guideline for endometriosis published on Saturday by Royal Australian and New Zealand College of Obstetricians and Gynaecologists (Ranzcog) recommends that a transvaginal ultrasound be used as the first-line investigation or, if not appropriate, a pelvic MRI.
The recommendations are based on emerging evidence suggesting that a greater number of cases can be diagnosed with these non-invasive techniques with increasing accuracy.
Sign up for Guardian Australia's breaking news email
The guideline replaces the first clinical practice guidelines published by Ranzcog in 2021. A 'living' guideline means recommendations are updated based on the latest research and emerging evidence.
Historically, the gold standard of diagnosing endometriosis was to take tissue from a patient during an operation and review it under a microscope. But research from a variety of groups shows ultrasound can detect deep infiltrating endometriosis with 'excellent' sensitivity, said Dr Marilla Druitt, a guideline developer. However this method does have limitations to detect superficial disease, she said.
While a traditional ultrasound looks at uterus, tubes and ovaries, a new Medicare item number for an endometriosis ultrasound will become available from November which will look for endometriosis tissue in places outside the uterus, including the ligament that holds the uterus to the inside of someone's pelvis.
'That Medicare item number will hopefully drive more thorough looking and more thorough assessment,' Druitt said. But in order for more patients with endometriosis to access it, more sonographers will need to gain accreditation, she said.
Offering ultrasound first to diagnose endometriosis means patients don't have to endure long wait lists for surgery before they can start accessing treatments, whether for sub-fertility or persistent pain.
The guidelines recommend starting 'with treatment and diagnosis in a parallel fashion, so there is absolutely no reason to delay treatment, which is the problem,' Druitt said.
The guidelines will also support GPs to begin first-line hormonal treatment while diagnostic investigations are under way, with primary care specific resources to improve access to key evidence-based recommendations.
Prof Danielle Mazza, the head of the department of general practice at Monash University and member of the guideline development group, said 'having clear, evidence-based tools like the quick reference guide and flowchart will be a gamechanger for primary care'.
The guidelines also now recommend physiotherapy and psychology care as potentially useful for people with pelvic pain and endometriosis.
The updated guidelines also say that people with endometriosis requesting information about cancer risk in reproductive organs, should be informed 'that although they may have a small increase in ovarian and endometrial cancer, the increase in absolute risk compared with women in the general population is low; and that they may have a reduced risk of cervical cancer'.
Druitt said many other inflammatory conditions, like Crohn's or rheumatoid arthritis, are also associated with a slightly higher cancer risk, but when it comes to endometriosis 'the fact that you need that massive data to be able to prove that association tells us something about the absolute risk is still pretty jolly small.'
Sign up to Breaking News Australia
Get the most important news as it breaks
after newsletter promotion
New resources for patients have also been developed.
Alexis Wolfe, consumer liaison on the guideline development group, said the resources will give people information that would help them advocate for themselves and participate more confidently in decision-making with care providers.
When it comes to the two different types of surgical treatments for endometriosis – ablation or excision – the guidelines state 'existing evidence does not support one technique over the other, with the exception of endometrioma [cysts on the ovaries]' with the certainty of evidence being identified as 'low'.
The guidelines strongly recommend excision rather than ablation to treat endometriomas.
Jess Taylor, the chair of peak body the Australian Coalition for Endometriosis (ACE), , said having a living guideline was 'critical' because endometriosis has a lot of new research activity. It was historically under-researched compared to other conditions, she said.
While supportive living guidelines for health professionals and patients, Taylor said it was disappointing Ranzcog did not allow open consultation to the public.
'We requested formal sector consultation … and we followed that up multiple times, and it's disappointing that did not happen for a guide as important as this,' Taylor said.
A Ranzcog spokesperson said they 'undertook sector consultation over a three-week period and extensions were granted where possible. The ACE requested a longer extension, which was not possible due to publication timelines.
The spokesperson said the timelines were made in agreement with the federal department of health who was the funder.
'We are now working with ACE and the Department of Health to ensure that ACE's feedback can be incorporated into the next updates.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
an hour ago
- Daily Mail
How a husband's split second decision when his pregnant wife went into labour saw his baby safely delivered in a very unusual location
A baby boy was born in a gym after a Melbourne couple realised that they wouldn't make it to the hospital in time. Mother Rachel Eastwood went into labour on July 29 with her fourth son, Daniel, but she and her husband Peter realised they had to change their plans. 'By the end of the street, I think Pete realised very quickly that we weren't going to make it to the hospital,' she told 7News on Thursday. 'So, very quickly, (we) started sort of problem solving around what our options were. 'Being members of the gym, Pete thought of the gym because he thought, well, there's a room that has towels heating. 'That's probably a much better option than the side of the road.' Mr Eastwood rang their midwife Sharon Williams to tell her about their new plan. The couple then rushed to the gym Strong & Stable in The Basin, eastern Melbourne, where the owner provided them with a room and bed. 'It was just instinct, really. You just know what to do. You just want her to be safe. Her baby to be safe,' Ms Williams said about the decision. 'It was great. We had privacy. We had a room that was warm, lots of towels,' Ms Williams said. 'So it all worked really well.' Daniel was born within 10 minutes, before the paramedics had even made it to the gym. The family was then taken to hospital before being discharged later that night.

Scotsman
2 hours ago
- Scotsman
Energetic labrador back on his paws following spinal surgery
A dog who was struggling to walk is back on his feet thanks to treatment from expert vets. Free weekly newsletter Join our weekly YourWorld newsletter for updates, behind-the-scenes insights from our editors and your chance to shape what's next. Free weekly newsletter Sign up Thank you for signing up! Did you know with a Digital Subscription to Edinburgh News, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... Seven-year-old labrador retriever Glen was suddenly unable to bear weight on his left back leg but seemed to improve following a course of steroids. Most Popular However, when he relapsed a few weeks later, Glen's local vet referred him to Linnaeus-owned Veterinary Specialists Scotland (VSS) in Livingston with suspected nerve damage. Advertisement Hide Ad Advertisement Hide Ad It was there he saw veterinary neurologist Camila Diogo, who carried out an MRI scan of Glen's back. The scan revealed a damaged disc which was pressing on Glen's spine. Glen Camila said: 'The scan revealed a marked spinal compression and I was surprised poor Glen was not showing more pain given the size of the protrusion. 'Our options were to start physiotherapy and continue with steroids or perform a partial discectomy to remove the protrusion and release pressure on the spinal cord.' After discussion, Glen's owner and Camila decided surgery would be the best long-term option and an operation was carried out to remove the damaged part of the disc. Advertisement Hide Ad Advertisement Hide Ad The surgery went well and Glen was quickly back on his feet and no longer struggling to weight bear on his back leg. Glen Relieved owner Jade Beaton, who lives in Arbroath, said: 'We had to restrict exercise for several weeks and attend physiotherapy, but Glen made a quick recovery from his surgery. 'We took him for walks with his sling for a while after the operation to allow his muscles to rebuild and so he could properly weight bear. 'Now, he's doing great and back to the crazy, energetic boy that he was before. It's great to see him back doing zoomies again! Advertisement Hide Ad Advertisement Hide Ad 'Camila was excellent. She kept us informed and explained things well, which made things so much easier.' Glen is back to full health following spinal surgery. VSS is a specialist-led multidisciplinary referral hospital offering services in cardiology, dermatology, emergency and critical care, internal medicine (feline and canine), neurology, orthopaedics, and soft tissue surgery, supported by specialists in diagnostic imaging and anaesthesia and analgesia. For more information about VSS and the services it offers, visit or search for Veterinary Specialists Scotland on social media.


Daily Mail
2 hours ago
- Daily Mail
Breakthrough as cheap medicine taken by millions is found to fight off the most deadly form of breast cancer
A cheap blood pressure drug already taken by millions could help protect women against one of the deadliest forms of breast cancer, new research suggests. Scientists at Monash University in Melbourne say beta blockers—which work by dampening the effects of stress hormones—may also halt the progression of triple negative breast cancer in some patients. The link between beta blockers and breast cancer first emerged in 2023, though it was not clear why. Now, researchers believe they have identified the mechanism—and with it, a potential low-cost treatment for an extremely aggressive disease. Their work looked at the interaction between two signalling molecules, cAMP and calcium, which accelerate cancer spread when a receptor called the beta-2 adrenoceptor is activated. Stress hormones such as cortisol can trigger this receptor, fuelling tumour growth. But the team has now discovered that beta blockers can switch off a gene—HOXC12 —which drives this process, slowing the progression of the disease. The researchers said the breakthrough could help doctors identify, at the point of diagnosis, which patients are most likely to benefit from beta blocker therapy. Beta blockers like atenolol work mainly by slowing down the heart by blocking the effect of stress hormones like adrenaline. They are currently used to treat a number of conditions including heart failure, high blood pressure and sometimes anxiety Professor Michelle Halls, senior author of the study and an expert in drug discovery biology at Monash Institute of Pharmaceutical Sciences, said the findings were exciting as they confirmed the potential link between beta blockers and tumour progression. 'Our colleagues previously found that beta blockers are associated with a significant reduction in mortality in people with triple negative breast cancer. 'Now we have a much better grasp on why this could be the case,' she said. Mr Terrance Lam, a pharmaceutical PhD candidate at the institute and co-author, added: 'Our collective research strongly suggests that HOXC12 is a potential new indicator for when triple negative breast cancer patients could respond to beta blocker targeted interventions. 'Triple negative breast cancer is an aggressive cancer which can be especially challenging to treat and identifying new treatment pathways are important.' The researchers are now calling for further studies to 'urgently' determine whether the gene can be used at diagnosis to identify patients who will benefit from beta blocker therapy—and stop their cancer spreading. Beta blockers, commonly prescribed to lower blood pressure, work mainly by slowing the heart and blocking the action of stress hormones such as adrenaline. According to the study, published in Science Signaling, there is a strong correlation between activation of the beta-2 adrenoceptor and accelerated cancer spread. They also found that patients with high levels of HOXC12 expression in women with this form of cancer were associated with poorer overall survival outcomes . One in seven women in the UK are diagnosed with breast cancer in their lifetime—around 56,000 a year—making it the most common cancer in the UK. Around 85 per cent of women diagnosed with breast cancer survive for more than five years following their diagnosis. However, triple negative breast cancer—which accounts for around 15 per cent of all breast cancers in the UK and US—is far more challenging to treat. Typically, it grows and spreads faster than other breast cancer types and has fewer treatment options. One reason for this is because it doesn't interact with hormones such as oestrogen in the same way as other breast cancers—for which there are targeted therapies. On average around 77 per cent of women with triple negative breast cancer will survive their cancer for five years or more after they are diagnosed, but depending on the stage this can fall as low as 12 per cent. This is compared to around 90 per cent of women with other forms of breast cancer who will survive for at least five years.